Maybe I’m missing something, but according to that link, only New Brunswick, the Northwest Territories, and Nunavut give the hep b vaccine at birth. Six of the provinces don’t even have an infant program at all (ie not even at 1/2 months).
The recommendation to give the first dose at birth only applies if the province actually has an infant program using monovalent vaccine, and almost none of them do.
Yes, the Canadian recommendations are to vaccinate at birth where there is an infant vaccine program or if the mother has a positive test. Whether only some or all of the provinces have programs to vaccinate at birth, i.e. before 2 months after birth, as was previously claimed to be the Canadian recommendation, seems not irrelevant to the argument, doesn’t it? My point was to stick to discussions of the actual recommendations, which are much more nuanced and dependent on specific circumstances than what is typically used to descend into some random political rant.
Similar nuance applies to the hepatitis B recommendations in the EU, where in some countries with low prenatal testing rate and high hepatitis B prevalence, such as Romania, the recommendation is to vaccinate at birth, while in countries with broad testing (and health insurance coverage), where incidentally the hepatitis B prevalence is low (mmh, wonder why? /s), positive test-dependent hepatitis B vaccination of newborns is indicated, and a later immunization of non-at-risk newborns can be recommended where prevalence is low and testing coverage broad. This contrasts with the US, where barriers to testing are higher and the uninsured rate (and decreased testing coverage) is over 15% (compared to < 0.2%-0.5% uninsured in the EU states with broad testing, or Canada), and the prevalence of hepatitis B in the uninsured population is high.